ELEANOR WELTGE: Open Payments
NPI 1023636321 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$13,510 in 93 payments from 7 companies in 2025. Trend: 2023 $5,118 · 2024 $4,711 · 2025 $13,510
Speaker / faculty: $7,030Food & beverage: $2,753Consulting: $1,916Travel & lodging: $1,811
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 20 | $5,609 |
| BridgeBio Pharma, Inc. | 16 | $3,658 |
| Abbott Laboratories | 44 | $2,918 |
| AstraZeneca Pharmaceuticals LP | 5 | $988 |
| Impulse Dynamics (USA) Inc. | 1 | $152 |
| Novartis Pharmaceuticals Corporation | 4 | $125 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $62 |
Products named: AMVUTTRA, Attruby, CARDIOMEMS, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, Optimizer, LEQVIO, ONPATTRO, WAINUA.
Industry payments across TX — which companies pay providers there.
